Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
The prognosis of pulmonary arterial hypertension (PAH) is poor; therefore, early diagnosis and treatment is required. However, the useful biomarkers for the diagnosis have not been established. In the present study, we examined whether oxidative stress-related proteins, such as glutathionylated protein and PGC-1α, could be the biomarkers, because oxidative stress is involved in PAH development and progression. As a result, the expression of the two proteins did not differ between PAH model and control animal. We concluded that these proteins were not good biomarkers for the diagnosis of PAH.
|